135 related articles for article (PubMed ID: 4018780)
1. Mesenchymal and muscle-specific intermediate filaments (vimentin and desmin) in relation to differentiation in childhood rhabdomyosarcomas.
Molenaar WM; Oosterhuis JW; Oosterhuis AM; Ramaekers FC
Hum Pathol; 1985 Aug; 16(8):838-43. PubMed ID: 4018780
[TBL] [Abstract][Full Text] [Related]
2. Rhabdomyosarcoma in childhood. An immunohistological analysis with myoglobin, desmin and vimentin.
Kodet R
Pathol Res Pract; 1989 Aug; 185(2):207-13. PubMed ID: 2798221
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis of human childhood rhabdomyosarcoma of antibodies to desmin, the structural protein of muscle specific intermediate filaments.
Altmannsberger M; Osborn M; Treuner J; Hölscher A; Weber K; Shauer A
Virchows Arch B Cell Pathol Incl Mol Pathol; 1982; 39(2):203-15. PubMed ID: 6177091
[TBL] [Abstract][Full Text] [Related]
4. [Rhabdomyosarcoma: morphology and cellular differentiation].
Schmidt D; Harms D; Reimann O; Treuner J
Klin Padiatr; 1986; 198(3):202-7. PubMed ID: 3523025
[TBL] [Abstract][Full Text] [Related]
5. Expression of desmin and myoglobin in rhabdomyosarcomas and in developing skeletal muscle.
Carter RL; McCarthy KP; Machin LG; Jameson CF; Philp ER; Pinkerton CR
Histopathology; 1989 Dec; 15(6):585-95. PubMed ID: 2558065
[TBL] [Abstract][Full Text] [Related]
6. Expression of developmentally regulated muscle proteins in rhabdomyosarcomas.
Wijnaendts LC; van der Linden JC; van Unnik AJ; Delemarre JF; Barbet JP; Butler-Browne GS; Meijer CJ
Am J Pathol; 1994 Oct; 145(4):895-901. PubMed ID: 7524332
[TBL] [Abstract][Full Text] [Related]
7. Myoglobin, desmin and vimentin in ultrastructurally proven rhabdomyomas and rhabdomyosarcomas. An immunohistochemical study utilizing a series of monoclonal and polyclonal antibodies.
Seidal T; Kindblom LG; Angervall L
Appl Pathol; 1987; 5(4):201-19. PubMed ID: 3689591
[TBL] [Abstract][Full Text] [Related]
8. Intermediate filament proteins and actin isoforms as markers for soft tissue tumor differentiation and origin. II. Rhabdomyosarcomas.
Skalli O; Gabbiani G; Babaï F; Seemayer TA; Pizzolato G; Schürch W
Am J Pathol; 1988 Mar; 130(3):515-31. PubMed ID: 3279794
[TBL] [Abstract][Full Text] [Related]
9. Expression of muscle-specific actins and myosin in light microscopically undifferentiated small and dark cell malignancies of soft tissues.
Seidal T; Angervall L; Kindblom LG
APMIS; 1990 Dec; 98(12):1105-12. PubMed ID: 2282206
[TBL] [Abstract][Full Text] [Related]
10. Therapy associated differentiation in rhabdomyosarcomas.
d'Amore ES; Tollot M; Stracca-Pansa V; Menegon A; Meli S; Carli M; Ninfo V
Mod Pathol; 1994 Jan; 7(1):69-75. PubMed ID: 8159655
[TBL] [Abstract][Full Text] [Related]
11. Desmin is a specific marker for rhabdomyosarcomas of human and rat origin.
Altmannsberger M; Weber K; Droste R; Osborn M
Am J Pathol; 1985 Jan; 118(1):85-95. PubMed ID: 3881039
[TBL] [Abstract][Full Text] [Related]
12. Cellular differentiation and prognosis in embryonal rhabdomyosarcoma. A report from the Cooperative Soft Tissue Sarcoma Study 1981 (CWS 81).
Schmidt D; Reimann O; Treuner J; Harms D
Virchows Arch A Pathol Anat Histopathol; 1986; 409(2):183-94. PubMed ID: 3012860
[TBL] [Abstract][Full Text] [Related]
13. Proteins of intermediate filaments. An immunohistochemical and biochemical approach to the classification of soft tissue tumors.
Denk H; Krepler R; Artlieb U; Gabbiani G; Rungger-Brändle E; Leoncini P; Franke WW
Am J Pathol; 1983 Feb; 110(2):193-208. PubMed ID: 6824065
[TBL] [Abstract][Full Text] [Related]
14. Embryonal rhabdomyosarcoma: immunohistochemical characterization.
Geiger S; Czernobilsky B; Marshak G; Geiger B
Oral Surg Oral Med Oral Pathol; 1985 Nov; 60(5):517-23. PubMed ID: 2414709
[TBL] [Abstract][Full Text] [Related]
15. Comparative phenotypes in rhabdomyosarcomas and developing skeletal muscle.
Carter RL; Jameson CF; Philp ER; Pinkerton CR
Histopathology; 1990 Oct; 17(4):301-9. PubMed ID: 2258169
[TBL] [Abstract][Full Text] [Related]
16. [Comparative observation of morphology and immunohistochemistry in rhabdomyosarcoma and fetal skeletal muscle].
Lai RQ
Zhonghua Bing Li Xue Za Zhi; 1993 Oct; 22(5):265-8. PubMed ID: 8168190
[TBL] [Abstract][Full Text] [Related]
17. Expression of intermediate filament desmin and vimentin in the human fetal heart.
Kim HD
Anat Rec; 1996 Oct; 246(2):271-8. PubMed ID: 8888968
[TBL] [Abstract][Full Text] [Related]
18. Expression of intermediate filaments in different human epithelial and mesenchymal tumors.
Altmannsberger M; Osborn M; Weber K; Schauer A
Pathol Res Pract; 1982; 175(2-3):227-37. PubMed ID: 6190146
[TBL] [Abstract][Full Text] [Related]
19. Colocalization of nestin and vimentin/desmin in skeletal muscle cells demonstrated by three-dimensional fluorescence digital imaging microscopy.
Sjöberg G; Jiang WQ; Ringertz NR; Lendahl U; Sejersen T
Exp Cell Res; 1994 Oct; 214(2):447-58. PubMed ID: 7925640
[TBL] [Abstract][Full Text] [Related]
20. Primitive neuroectodermal tumors of the central nervous system. Patterns of expression of neuroendocrine markers, and all classes of intermediate filament proteins.
Gould VE; Jansson DS; Molenaar WM; Rorke LB; Trojanowski JQ; Lee VM; Packer RJ; Franke WW
Lab Invest; 1990 Apr; 62(4):498-509. PubMed ID: 2159086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
